AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 188 filers reported holding AKERO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,281,278 | +25.6% | 183,497 | +15.9% | 0.06% | +31.0% |
| Q2 2023 | $7,389,720 | +17.4% | 158,272 | -3.8% | 0.04% | -2.3% |
| Q1 2023 | $6,293,885 | -38.8% | 164,503 | -12.4% | 0.04% | -50.0% |
| Q4 2022 | $10,291,385 | +975.4% | 187,799 | +178.4% | 0.09% | +1333.3% |
| Q1 2022 | $957,000 | -19.4% | 67,455 | +20.1% | 0.01% | 0.0% |
| Q4 2021 | $1,188,000 | +26.5% | 56,159 | +33.6% | 0.01% | 0.0% |
| Q3 2021 | $939,000 | -19.5% | 42,024 | -10.7% | 0.01% | -14.3% |
| Q2 2021 | $1,167,000 | -14.9% | 47,048 | -0.5% | 0.01% | -22.2% |
| Q1 2021 | $1,371,000 | +501.3% | 47,270 | +435.8% | 0.01% | +350.0% |
| Q4 2020 | $228,000 | – | 8,822 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 5,830,203 | $179,512,000 | 24.20% |
| venBio Partners LLC | 2,444,311 | $75,260,000 | 11.44% |
| Versant Venture Management, LLC | 777,727 | $23,946,000 | 4.38% |
| Redmile Group, LLC | 2,336,357 | $71,936,000 | 1.32% |
| Vivo Capital, LLC | 571,833 | $17,607,000 | 1.02% |
| Cormorant Asset Management, LP | 859,550 | $26,466,000 | 1.02% |
| Boxer Capital, LLC | 831,495 | $25,602,000 | 0.88% |
| Integral Health Asset Management, LLC | 85,000 | $2,617,000 | 0.80% |
| EAM Global Investors LLC | 49,718 | $1,531,000 | 0.56% |
| Crawford Lake Capital Management, LLC | 43,826 | $1,349,000 | 0.56% |